Questions: Genetic Heterogeneity and Locus Heterogeneity

Question 1

Two individuals, each deaf due to autosomal recessive hearing loss, marry. Surprisingly, all of their children have normal hearing. What is the most likely genetic explanation?

• A. The children are carriers of both mutations, but the recessive alleles complement each other within the same cell
• B. Locus heterogeneity — each parent carries a loss-of-function mutation in a different gene required for hearing, so each child inherits one functional copy of both genes
• C. Allelic heterogeneity — both parents have mutations in the same gene, but different alleles that cancel out
• D. The mutations are dominant negative in each parent but recessive when inherited together

Answer: (B)

This is the classic complementation test for locus heterogeneity. Each parent is homozygous for a recessive mutation in a different gene. Their children inherit a mutant allele from each parent's respective locus, but also inherit a wild-type allele from the other parent — so both genes are functional and hearing is normal. If both parents had mutations in the same gene, all children would be deaf. Option C misunderstands allelic heterogeneity, which refers to different clinical outcomes from different mutations in the same gene, not alleles that 'cancel out.'

Question 2

Two families both receive a diagnosis of 'familial retinitis pigmentosa.' Genetic testing reveals Family A has a mutation in RHODOPSIN and Family B has a mutation in RPGR. A genetic counselor tells Family A that carriers of one RHODOPSIN mutation are at elevated risk. Is this advice applicable to Family B's unaffected relatives?

• A. Yes — both families have retinitis pigmentosa, so the risk structure and inheritance pattern are the same
• B. No — Family B's risk depends on their RPGR mutation; their RHODOPSIN status is irrelevant to retinitis pigmentosa in their family
• C. Partly — Family B is at lower risk because having a second causal gene available provides partial compensation
• D. Yes — retinitis pigmentosa is a single-gene disease, so all families share the same underlying genetic mechanism

Answer: (B)

Locus heterogeneity means the same clinical diagnosis can be caused by mutations in different genes. Family B's risk depends entirely on RPGR, not RHODOPSIN. An unaffected Family B relative who happens to carry a RHODOPSIN variant has no elevated retinitis pigmentosa risk from that allele (assuming RPGR is the causal gene in their family). This is why genetic counseling requires identifying the specific gene and mutation, not just the clinical diagnosis — 'same disease' does not mean 'same gene.'

Question 3

Locus heterogeneity can be revealed by complementation testing: if two individuals with the same recessive phenotype produce children with a normal phenotype, their mutations are likely in different genes.

• T. True
• F. False

Answer: True

Complementation is the definitive test for locus heterogeneity. If each parent's mutation is in a different gene, their children inherit one functional copy of each gene from the unaffected parent at the other locus — and both genes are functional, producing a normal phenotype. This directly demonstrates that the same phenotype arose from two different genetic causes. Historically, complementation testing has been a primary tool for determining whether distinct mutations represent one gene or multiple genes.

Question 4

Allelic heterogeneity means that people with different mutations in the same gene will typically show the same clinical phenotype, since they share the same underlying genetic locus.

• T. True
• F. False

Answer: False

Allelic heterogeneity is precisely the phenomenon where different mutations in the same gene produce different clinical outcomes. CFTR is the textbook case: the ΔF508 mutation causes severe cystic fibrosis with lung disease and pancreatic insufficiency, while other CFTR mutations cause only male infertility or chronic pancreatitis. The clinical spectrum maps onto residual protein function — mutations that prevent the protein from reaching the cell surface at all produce severe disease; those that allow a partially functional channel produce milder phenotypes. 'Same gene, same disease' is the misconception.

Question 5

Explain why locus heterogeneity complicates genetic linkage studies, and what strategy researchers can use to overcome this problem.

Model answer: In a linkage study, researchers look for chromosomal regions that co-segregate with a disease across many families. If a disease shows locus heterogeneity — caused by mutations in different genes in different families — pooling all families together dilutes the signal from each locus. Families whose disease maps to chromosome 1 cancel out signal from families whose disease maps to chromosome 17, and no region may reach statistical significance. The solution is stratification: identify clinical subtypes or complementation groups that may correspond to distinct genetic causes, and analyze each subgroup separately. Alternatively, use heterogeneity LOD score methods (HLOD) that can detect linkage when only a fraction of families carry mutations at a given locus.

The same logic applies to modern GWAS studies — pooling genetically heterogeneous cases can wash out real signals. Subgroup analyses by clinical severity, age of onset, or other features that correlate with genetic cause are often the key to successful gene discovery in heterogeneous diseases.